Synthesis of Carboranyl Flurbiprofen and Its Biological Evaluation—An Example of Carborane Not as a Phenyl Ring Surrogate

Read full text
Authors: Chaofan Li, Chenyang Ma, Yuxin Lin, Changxian Yuan, Guanxiang Hao, Zhiguang Zhang, Sinan Wang
Cited by: 1
References: 32

Abstract

ABSTRACT “Carborane replacing phenyl ring” strategy has been frequently applied in drug modification because of the similar hydrophobicity and size between carborane and a rotational phenyl ring. We replaced the terminal phenyl ring of an NSAID flurbiprofen with carborane and synthesized the carboranyl flurbiprofen successfully. The carboranyl flurbiprofen lost its inhibitory activity toward COX‐1 and COX‐2, suggesting that carborane could not always serve as a phenyl ring surrogate. The biodistribution of carboranyl flurbiprofen was measured using ICP‐MS, revealing a high uptake in the liver, kidney and pancreas. The brain/blood ratio was 0.27 at 5 h post‐injection, suggesting an enhanced blood‐brain barrier permeability.

Fields of Study & Subjects

Boron Compounds in Chemistry Radiopharmaceutical Chemistry and Applications Bone health and treatments

Publication details

Journal / source
ChemistrySelect
Publisher
Wiley
Volume
11
Issue
5
Publication date
1 February 2026
Language
EN